Stock comparison

GILDvsVRTX

Gilead Sciences IncvsVertex Pharmaceuticals Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

GILD

Gilead Sciences Inc

$133.64

+10.12%

Biotechnology$173.4BNASDAQ

VRTX

Vertex Pharmaceuticals Inc

$435.1

-4.37%

Biotechnology$119.2BNASDAQ

60-day price, rebased to 100

GILD -6.47% · VRTX -7.41%

Round-by-round

GILD 4·VRTX 1· 1tie

EdgeGILD

Valuation upside

-27.50% vs -43.10% to DCF fair value

EdgeVRTX

Balance-sheet strength

Altman Z 4.47 vs 12.39

EdgeGILD

Fundamental quality

Piotroski 8.00 vs 6.00 (of 9)

Tie

Growth + margins

Rule-of-40 34.50 vs 35.50

EdgeGILD

60-day momentum

-6.47% vs -7.41% price return

EdgeGILD

Market-cap liquidity

$173.4B vs $119.2B

Verdict

Across6categories,GILDtakes the edge with4wins to1 (and 1 tie). Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onGILDorVRTX

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.